Gao Y, Liu Y, Wang Y, Zhang Q, et al. Bendamustine in the treatment of patients with indolent non-Hodgkin lymphoma refractory or relapse to rituximab treatment: An open-label, single-agent, multicenter study in China. Cancer 2022 Dec 21. doi: 10.1002/cncr.34544.
PMID: 36541221